Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Suppressor Protein p53 | 11 | 2011 | 299 | 2.090 |
Why?
|
| Cell Cycle Proteins | 5 | 2011 | 375 | 0.760 |
Why?
|
| Glucose | 2 | 2015 | 444 | 0.680 |
Why?
|
| Serine | 3 | 2010 | 83 | 0.600 |
Why?
|
| Apoptosis | 5 | 2010 | 1038 | 0.570 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2015 | 42 | 0.480 |
Why?
|
| Prediabetic State | 1 | 2015 | 52 | 0.460 |
Why?
|
| Insulin Resistance | 2 | 2015 | 403 | 0.450 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2011 | 193 | 0.430 |
Why?
|
| Fibroblasts | 8 | 2015 | 367 | 0.420 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2010 | 192 | 0.410 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2011 | 484 | 0.380 |
Why?
|
| Nuclear Localization Signals | 1 | 2010 | 18 | 0.370 |
Why?
|
| Neural Tube Defects | 1 | 2010 | 27 | 0.360 |
Why?
|
| DNA-Binding Proteins | 3 | 2011 | 1128 | 0.340 |
Why?
|
| Lymphoma, B-Cell | 1 | 2010 | 59 | 0.340 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2010 | 99 | 0.330 |
Why?
|
| Signal Transduction | 6 | 2015 | 2890 | 0.310 |
Why?
|
| Homeostasis | 1 | 2010 | 340 | 0.300 |
Why?
|
| Phosphorylation | 5 | 2011 | 861 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 7 | 2015 | 3189 | 0.300 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 675 | 0.290 |
Why?
|
| Mice | 13 | 2015 | 10256 | 0.290 |
Why?
|
| DNA Fragmentation | 1 | 2006 | 35 | 0.270 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2006 | 123 | 0.270 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 3 | 2011 | 43 | 0.260 |
Why?
|
| Nuclear Proteins | 2 | 2010 | 759 | 0.220 |
Why?
|
| Animals | 13 | 2015 | 19610 | 0.210 |
Why?
|
| Histones | 1 | 2006 | 463 | 0.210 |
Why?
|
| Germ-Line Mutation | 2 | 2011 | 47 | 0.170 |
Why?
|
| Animals, Genetically Modified | 2 | 2010 | 281 | 0.170 |
Why?
|
| Insulin | 2 | 2015 | 687 | 0.160 |
Why?
|
| Antioxidants | 2 | 2010 | 243 | 0.150 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2103 | 0.150 |
Why?
|
| Mice, Knockout | 4 | 2015 | 1988 | 0.150 |
Why?
|
| Cell Proliferation | 2 | 2011 | 944 | 0.140 |
Why?
|
| Cellular Senescence | 2 | 2007 | 103 | 0.140 |
Why?
|
| Mutation | 3 | 2011 | 2427 | 0.130 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2015 | 4 | 0.120 |
Why?
|
| Protein Phosphatase 2C | 1 | 2015 | 4 | 0.120 |
Why?
|
| Diet, Fat-Restricted | 1 | 2015 | 36 | 0.120 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 75 | 0.120 |
Why?
|
| Leptin | 1 | 2015 | 78 | 0.120 |
Why?
|
| Glucose Intolerance | 1 | 2015 | 88 | 0.110 |
Why?
|
| Diet, High-Fat | 1 | 2015 | 159 | 0.110 |
Why?
|
| Dietary Fats | 1 | 2015 | 204 | 0.110 |
Why?
|
| Interleukin-6 | 1 | 2015 | 309 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 2 | 2010 | 64 | 0.100 |
Why?
|
| Reactive Oxygen Species | 2 | 2010 | 201 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 315 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 580 | 0.100 |
Why?
|
| Cell Division | 3 | 2007 | 442 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 677 | 0.090 |
Why?
|
| Peroxidases | 1 | 2010 | 7 | 0.090 |
Why?
|
| Genes, Lethal | 1 | 2010 | 41 | 0.090 |
Why?
|
| Genes, ras | 1 | 2010 | 28 | 0.090 |
Why?
|
| Ataxia Telangiectasia | 1 | 2010 | 12 | 0.090 |
Why?
|
| Homozygote | 1 | 2010 | 117 | 0.090 |
Why?
|
| Models, Genetic | 1 | 2011 | 253 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2010 | 35 | 0.090 |
Why?
|
| Heat-Shock Proteins | 1 | 2010 | 66 | 0.090 |
Why?
|
| Ultraviolet Rays | 1 | 2010 | 125 | 0.090 |
Why?
|
| Oncogenes | 1 | 2010 | 68 | 0.080 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2010 | 79 | 0.080 |
Why?
|
| Embryo, Mammalian | 2 | 2007 | 161 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 149 | 0.080 |
Why?
|
| Cell Survival | 1 | 2010 | 553 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2010 | 363 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2010 | 379 | 0.080 |
Why?
|
| Immunoglobulin G | 1 | 2010 | 451 | 0.080 |
Why?
|
| DNA Damage | 1 | 2010 | 277 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 1221 | 0.070 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2007 | 37 | 0.070 |
Why?
|
| Genes, p53 | 2 | 2007 | 53 | 0.070 |
Why?
|
| Obesity | 1 | 2015 | 1189 | 0.070 |
Why?
|
| Male | 4 | 2015 | 27483 | 0.070 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 1582 | 0.070 |
Why?
|
| Genotype | 1 | 2007 | 644 | 0.060 |
Why?
|
| Proteins | 1 | 2010 | 742 | 0.060 |
Why?
|
| Phosphotransferases | 1 | 2004 | 21 | 0.060 |
Why?
|
| Cyclins | 1 | 2004 | 40 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2004 | 40 | 0.060 |
Why?
|
| Acetylation | 1 | 2003 | 111 | 0.050 |
Why?
|
| ras Proteins | 1 | 2003 | 78 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2003 | 82 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 396 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2003 | 188 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 201 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2003 | 506 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 1129 | 0.050 |
Why?
|
| Alleles | 1 | 2003 | 425 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2003 | 255 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 663 | 0.050 |
Why?
|
| Female | 4 | 2011 | 30806 | 0.040 |
Why?
|
| Humans | 3 | 2011 | 59320 | 0.040 |
Why?
|
| Neoplasms | 1 | 2007 | 1234 | 0.040 |
Why?
|
| Aging | 1 | 2003 | 723 | 0.030 |
Why?
|
| Time Factors | 1 | 2004 | 3567 | 0.030 |
Why?
|
| Mammary Glands, Animal | 1 | 2010 | 79 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 149 | 0.020 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2010 | 77 | 0.020 |
Why?
|
| Cytidine Deaminase | 1 | 2010 | 81 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2010 | 553 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 525 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 595 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 880 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 671 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2007 | 22 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2007 | 139 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 500 | 0.020 |
Why?
|
| Kinetics | 1 | 2007 | 733 | 0.020 |
Why?
|
| E2F Transcription Factors | 1 | 2004 | 16 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 52 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 2062 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 2003 | 73 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2003 | 259 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 475 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2004 | 209 | 0.010 |
Why?
|
| Cell Line | 1 | 2003 | 2014 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2004 | 1456 | 0.010 |
Why?
|